"Drug Discovery & Development, Current Status and Future Prospects”
George Scangos, PhD, CEO, Biogen, Chairman-Elect of the Board of Directors of Pharmaceutical Research and Manufacturers of America (PhRMA)
5:30PM Registration & cocktails
6:00PM Welcome Remarks
6:05PM Keynote Session with George A. Scangos, Ph.D., CEO, Biogen
MC: Alireza Haghighi, M.D., D.Phil., Harvard Medical School, Brigham and Women’s Hospital
7:15PMQuestions & Discussion followed by Networking
This event serves as a joint collaboration between the Swedish American Chamber of Commerce New England and the British American Business Council in New England.
About our speaker:
George A. Scangos, Ph.D. was appointed Chief Executive Officer and a member of the Board of Directors in June 2010. George Scangos has been named as one of the world’s ten best performing CEOs by Harvard Business Review. The company’s share price has climbed more than 700 percent during Scangos’s tenure. Before joining Biogen, Dr Sacngos served as President and CEO and a director at Exelixis, Inc. (1996-2010), SVP of R&D, and President of Bayer Biotechnology at Bayer (1987-1996) and a professor of biology at Johns Hopkins University where he is still an adjunct professor. He currently serves on the Board of Directors of Exelixis, Agilent Technologies, the Board of Advisors for the UC Davis School of Medicine and the Board of Trustees for the Boston Museum of Science.
Biogen is the third largest biotechnology company in the world, which specializes in the discovery, development, and delivery of therapies for the treatment of neurodegenerative, hematologic, and autoimmune diseases. Biogen was ranked as the #1 most sustainable company in the world in 2015.
GET YOUR TICKETS HERE
(***FREE for SACC-NE STUDENTs members with current student ID***)
Location: One Federal Street, Boston MA. Parking is available at garage under building, at own cost. Picture ID is required for entry into the building. Public Transportation – South Station & State Street T stops.